ArticleHepatology communications2026

Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy.

Satoshi Shigeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.